Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Rind-based techniques can lower scalp radiation dose and reduce hair loss in brain cancer treatment.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Aromatase inhibitors cause male pattern hair loss in women.

EGFR inhibitors can cause yellowish skin eruptions.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Thymosin β4 helps increase hair growth in Cashmere goats.